Genprex, Inc. (GNPX)
2025-06-30 | ||||
|---|---|---|---|---|
| Realized and unrealized gain (loss) | 2 | |||
| Research and development | 2,499,495 | |||
| General and administrative | 2,182,289 | |||
| Depreciation | - | |||
| Total operating expenses | 4,681,784 | |||
| Operating loss | -4,681,784 | |||
| Other income | 6,881 | |||
| Net loss | -4,674,901 | |||
| Deemed dividend related to warrant modification | - | |||
| Net loss attributable to common stockholders | -4,674,901 | |||
| Net loss per share applicable to common stockholders basic and diluted (in dollars per share) | -0.17 | |||
| Weighted average number of common shares basic and diluted (in shares) | 27,593,952 | |||